Pulse Biosciences annual operating margin
2021
2022
2025
Pulse Biosciences Operating Margin Growth & History (PLSE)
Pulse Biosciences's operating margin was −21,982.57% for fiscal 2025.
View full Pulse Biosciences company overviewPulse Biosciences annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −21,982.57% | −13688.71 pp |
| 2022 | 2022-12-31 | −8,293.86% | −3849.99 pp |
| 2021 | 2021-12-31 | −4,443.86% | — |
Pulse Biosciences quarterly operating margin
Q3.21
Q1.22
Q2.22
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −5,823.04% | −534.74 pp |
| Q1 2026 | 2026-03-31 | −4,775.56% | −885.25 pp |
| Q4 2025 | 2025-12-31 | −6,914.02% | −4427.43 pp |
| Q3 2025 | 2025-09-30 | −23,682.56% | — |
| Q2 2022 | 2022-06-30 | −5,288.30% | — |
| Q1 2022 | 2022-03-31 | −3,890.32% | — |
| Q3 2021 | 2021-09-30 | −2,486.59% | — |
Pulse Biosciences operating margin trends
Across the available reported history, Pulse Biosciences's operating margin decreased from −8,293.86% to −21,982.57%, a change of −13688.71 percentage points. The latest reported quarter, Q2 2026, shows −5,823.04%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Pulse Biosciences filings at SEC.gov ↗